|
Keynote Forum
Time: 08:20-11:40, January 25, 2011(Tuesday), Conference Hall, 4F, XICC
|
|
Opening Ceremony
|
| Moderator |
Dr. Ruian Xu, Professor and Director, Engineering Research Center of Molecular Medicine, Ministry of Education & Institute of Molecular Medicine, Huaqiao University, China
|
|
08:20-08:40
|
Group Photo
|
|
09:00-09:05
|
Chair' s Opening Remark
|
|
09:05-09:35
|
VIP' s Address
|
|
Keynote Forum
|
|
09:40-10:10
|
Title: The Huge Regulatory, Clinical, and Commercial Challenges of Developing Metabolic Therapies Today
Dr. G. Alexander Fleming, President and CEO, Kinexum LLC, USA
|
|
10:10-10:40
|
Title: Aldose Reductase Genetic Deficiency Significantly Ameliorates the Development of Diabetic Nephropathy in C57BL/6 Mice
Dr. James Y. Yang, Professor, Department of Biomedical Sciences, School of Life Sciences, Xiamen University, China
|
|
10:40-11:10
|
Title: Promise and Pitfalls of Designer Biologics in Metabolic Medicine
Dr. Michael R. Hanley, Chief Scientific Officer, Amylin Pharmaceuticals, Inc., USA
|
|
11:10-11:40
|
Title: Potential and Challenge of Diabetes Gene Therapy
Dr. Ruian Xu, Professor and Director, Engineering Research Center of Molecular Medicine, Ministry of Education & Institute of Molecular Medicine, Huaqiao University, China
|
|
